Dr. Stephen Brecher, Speaker and Consultant  
   
  HomeTopics and AudiencesSample SlidesContact  
About Me
Biographical Sketch
Curriculum Vitae

Biographical Sketch
^ back to top

Dr. Stephen M. Brecher is the Director of the Microbiology Laboratories of the Boston VA Healthcare System, an Associate Professor of Pathology and Laboratory Medicine at the Boston University School of Medicine, and an adjunct Associate Professor of Medical Technology at the University of Massachusetts, Dartmouth Campus. Dr. Brecher has been honored as an American Society of Microbiology (ASM) Foundation Speaker and has convened and lectured at workshops on antibiotic resistance for the ASM at annual meetings and at ICAAC (the “infections meeting”). Dr. Brecher has served on numerous Speaker’s Bureaus and Advisory Boards.

Dr. Brecher is an international speaker on many topics, but his favorites are C. difficile Infections and antibiotic resistance. An accomplished and highly acclaimed speaker, Dr. Brecher is well known and appreciated for his ability to make you laugh while he is telling you that bacteria are the dominant species on the earth and that your days are numbered.

Dr. Stephen Brecher
Curriculum Vitae
^ back to top

Index
Education
^ back to index

1975-79Northeastern University, Boston, MA Microbiology, Ph.D.
Dissertation title: Studies on the Adherence and Colonization of Actinomyces viscosus. (Research performed at Forsyth Dental Center)
1972-75Northeastern University, Boston, MA Biology, M.S.
1963-67University of Massachusetts, Amherst, MA Microbiology, B.S.

Employment
^ back to index

1983-Chief, Departments of Microbiology,
VA Boston Healthcare System, Boston, MA
1981-83Director of Microbiology,
International Clinical Laboratory, Randolph, MA
1981Postdoctoral Research Associate,
Massachusetts Institute of Technology, Cambridge, MA
Visiting Lecturer,
Northeastern University, Boston, MA
1980Visiting Assistant Professor,
Wesleyan University, Middleton, CT
1979-80Postdoctoral Research, Forsyth Dental Center, Boston, MA
1978-79Instructor of Microbiology,
Boston University, Boston, MA
1973-78Instructor of Microbiology,
Northeastern University, Boston, MA
1972-73Teaching Assistant, Northeastern University, Boston, MA
1969-71Chief, Bacteriology Laboratory, North Shore Children's Hospital, Salem, MA
1967-69Bacteriologist, Tufts-New England Medical Center,
Boston, MA
Academic Appointments
 Assistant Professor of Pathology
Boston University School of Medicine, Boston, MA
Adjunct Associate Professor of Microbiology,
University of Massachusetts/Darthmouth, Dartmouth, MA

Current Employment Summary
^ back to index

Chief, Department of Microbiology, Boston Veterans Affairs Medical Center, Boston, MA

I am the Chief of the Departments of Microbiology at the VA Healthcare System of Boston and I am responsible for the overall operation of the College of American Pathology certified clinical microbiology laboratories at a number of campuses. I participate in teaching programs for interns, residents and fellows. My research interests include issues of antibiotic resistance (particularly MRSA and VISA), Clostridium difficile Diagnosis/infections, and molecular epidemiology. Also, I lecture, teach, mentor medical students, interns, residents, fellows, and professional and clinical staff at the VA Medical Center.

Associate Professor of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA

I lecture to second year medical and dental students in the Biology of Disease course.

Associate Professor of Biology, University of Massachusetts/Dartmouth, Dartmouth, MA

I coordinate the medical technology internship program with the VA.

Other Career and Community Activities
^ back to index

Speakers Bureaus
  • Merck
Advisory Boards
  • Bacterioscan
  • Cempra
  • First Light Bioscience
Other Activities
  • CLSI (Observer, Antibiotic Subcommittee)
  • Inspector (College of American Pathology)
  • Alliance for the Prudent Use of Antibiotics (APUA)
Honors / Honor Societies
  • American Society for Microbiology Foundation Speaker (1999-2001)
  • Phi Sigma Society
  • Sigma Xi Society
  • Finalist for the Excellence in Government Award (2005)
  • AAAC Outstanding Speaker Award (2013)
  • Brian Hoffman Distinguished Teaching Award (2015)
Editorial Boards
  • Journal of Clinical Microbiology 2002-
  • The Prostate Journal 1999-2002
Community Activities (Over the Years)
  • Touchdown Club (Town of Needham)
  • Little League Coach (Town of Needham)
  • Track Coach (Needham Summer Program)
  • HIV Task Force (Town of Needham)
  • Basketball Coach (Town of Needham)
  • Health Advisory Committee (Town of Needham)
Professional Memberships
  • American Society for Microbiology (ASM)
  • Infectious Disease Society of America (IDSA)
  • Alliance for the Prudent Use of Antibiotics
  • Association of VA Clinical Microbiologists (President 1992-93)
  • Massachusetts Division, Infectious Disease Society of America
  • Northeast Association for Clinical Microbiology and Infectious Disease
  • Northeast Branch, American Society for Microbiology
Publications
^ back to index
  1. Brecher, S., J. van Houte and B.F. Hammond. 1978. Role of Colonization in the Virulence of Actinomyces viscosus Strains T14-Vi and T14-Av. Infect. Immun. 22:603-614.
  2. Brecher, S. and J. van Houte. 1979. Increased Oral Colonization of Actinomyces viscosus During Aging of Sprague-Dawley Rats. Infect. Immun. 26:1137-1145.
  3. Yanover, L., J. van Houte and S. Brecher. 1981. Streptococcus mutans in Saliva: Relationship Between Parents and Their Children. Arch. Oral Biology. 26:381-386.
  4. Crowe, H.M. and S.M. Brecher. 1987. Nosocomial Septicemia with CDC Group IV c-2, an Unusual Gram-Negative Bacillus. J. Clin. Microbiol. 25:2225-2226.
  5. Epstein, S., C.W. Winslow, S.M. Brecher and L.J. Faling. 1992. Polymicrobial Bacterial Pericarditis after Transbronchial Needle Aspiration. Am. Rev. Respir. Dis. 146: 523-525.
  6. Chodosh, S., J. Tuck, D. Pizzuto, S. Brecher and K. Stottmeier. 1992. Comparison of Treatment of Acute Bacterial Exacerbations of Chronic Brohchial Disease with Temafloxacin or Ciprofloxacin. Infections in Medicine. Accepted for publication (Withdrawn when Temofloxacin was taken off the market).
  7. Jones, R.N., M.E. Erwin and the Ofloxacin Surveillance Group. 1992. USA Comparative Susceptibility of Ofloxacin (OFX) and Other Oral Antibiotics. A 35 Medical Center Controlled Investigation. Diagn Microbiol and Inf Dis. 15:425-434.
  8. Maslow, J.N., S. Loring, A. Durbin, S. Brecher and R. Arbeit. 1993. Klebsiella Isolates Designated as K. pneumoniae and K. oxytoca by API and Vitek Were Identified as Clonal by Pulsed Field Gel Electorphoresis (PFGE). J Clin Microbiol. 31:2000-2003.
  9. Kristjansson, M., P. Green, H.L. Manning, A.M. Slutsky, S.M. Brecher, C.F. von Reyn, R.D. Arbeit and J.N. Maslow. 1993. Molecular Confirmation of Bacillus Calmette-Guerin (BCG) as the Cause of Pulmonary Infection following Urinary Tract Instillation. Clin Infect Dis. 17: 228-230.
  10. Jones, R. N. and the North American Ofloxacin Study Group.. 1994. North American Comparative Susceptibility of Two Fluoroquinolones: Ofloxacin and Ciprofloxacin. Diagn Microbiol Infect Dis. 18: 49-56.
  11. Maslow,J.N., S.M. Brecher, J. Gunn, A. Durbin, M. A. Barlow and R. D. Arbeit. 1995. Variation and Persistance of Methicillin Resistant Staphylococcus aureus Among Individual Patients Over Extended Periods. Eur J Clin Micro and Inf Dis. 14: 282-290.
  12. Morris, T., S. M. Brecher, D. Fitzsimmons, R.D. Arbeit and J.N. Maslow. 1995. A Pseudoepidemic of Septic Arthritis. Infect Control Hosp Epidemiol. 16: 82-87.
  13. Huang, Q. and S. M. Brecher. 1996. Streptococcal Toxic Shock Syndrome. Check Sample. American Society of Clinical Pathologists. Microbiology 96-4:45-58.
  14. Brecher, S. 1997. The Role of Humans in the “Re-Evolution” of Bacteria. Clin Micro Newsletter. Invited editorial. 19: 61-64.
  15. Smole, S.C., E. Aronson, A. Durbin. S. M. Brecher and R. D. Arbeit. 1998. Sensitivity and Specificity of an Improved Rapid Latex Agglutination for the Identification of Methicillin-Sensitive and Resistant Staphylococcus aureus.. J. Clin. Microbiol. 36: 1109-1112.
  16. Jones, R. N. and the Cefepime Study Group. 1998. Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum B-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States. Diagn. Microbiol. Infect. Dis. 30: 215-228.
  17. Pfaller, M. A. and the Sentry Participant Group. 1998. International Surveillance of Bloodsstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the Sentry Program. J. Clin. Microbiol. 36: 1886-1889.
  18. Pfaller, M. A. and the Sentry Participant Group. 1998. Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Sosceptibility Patterns form the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 42: 1762-1770.
  19. Doern, G. V. and the SENTRY Participants Group. 1999. Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the Sentry Antimicrobial surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 43: 385-389.
  20. Zacks, J.F. and S. M. Brecher. 1999. Acute and Chronic Prostatitis Syndromes: A Review of Microbiologic and Pathologic Issues. The Prostate Journal. 1: 68-72.
  21. Shannon, R.J., M. Allen, A. Durbin, S. Brecher and R. Goodman. 1999. Patient Bath Water as a Significant Source of Nosocomial Microbiological Contamination. J Healthcare, Safety, Compliance and Inf. Control. 3:180-184.
  22. Clairmont, C. et al. 2000. Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP 20009, Genetically Modified Strain of Salmonella typhimurium: Journal of Infectious Disease. 181: 1996-2002.
  23. Nagendra, S., et al. 2001. Sampling Variability in the Microbiological Evaluation of Expectorated Sputa and Endotracheal Aspirates. J. Clin. Microbiol. 39: 2344-2347.
  24. Spira. A, S. Brecher, and J. Karlinsky. 2002. Pulmonary Mucormycosis in the Setting of Chronic Obstructive Plumonary Disease. A Case Report and Review of the Literature. Respiration. 69: 560-563.
  25. Oliveira, K., S. Brecher et al. 2003. Direct Identification of Staphylococcus aureus from Positive Blood Cultures. J. Clin. Microbiol. 41: 889-891.
  26. Brecher, S. and C. Ginnochio. 2003. Changes in the NCCLS Breakpoints and Laboratory Reporting Strategies for Ceftriaxone / Cefotaxime and Streptococcus pneumoniae. Clin. Micro. Newsletter. 25: 129-135.
  27. Gavin, P.J. et al. 2006. Clinical Correlation of the CLSI Susceptibility Breakpoints for Piperacillin-Tazobactam against ESBL-Producing Escerchia coli and Klebsiella species. Antimicrob. Agents Chemother. 50: 2244-2247.
  28. Reidel, S. et al. The Timing of Specimen Collection for Blood Cultures in Febrile Patients with Bacteremia. J Clin Microbiol. 46: 1381-1385. 2008
  29. Doern, G.V. et al. Supplement to Clinical Infectious Disease on the Laboratory Diagnosis of Infection. Clin Infect Dis (to be published in 2010)
  30. Baker, S. E. et al. 2010. Extra-Nasal MRSA Colonization on Admission to an Acute Care Veterans Affairs Hospital. Infect Control Hosp Epidemiol 32: 42-46
  31. Hansen, G. et al. 2010. Navigating the Available Testing Options for Diagnosing Clostridium difficile. Manuscript in Progress.
  32. Doern, G.V. and S. M. Brecher. 2011. The Clinical Value (or lack thereof) of the Results of In-Vitro Antimicrobial Susceptibility Tests). J Clin Microbiol. 49: S11-S14.
  33. Reslan, O.M. et al. 2012. Acute Expansion of a Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Mycotic Aortic Aneurysm. Annals of Vascular Surgery. 26:732e1-732e6.
  34. Tenover, F. C. et al. (part of the MRSA Consortium). 2012. Characterization of Nasal and Blood Culture Isolates of Methicillin-Resistant Staphylococcus aureus from Patients in United States Hospitals. Antimicrob. Agents Chemother.56: 1324-1330
  35. Weir, S.K. et al. 2012. Molecular Epidemiology of Newly Identified MRSA Nasal Carriage. 2012. J Clin. Microbiol. 50: 3283-3286
  36. Wood, J.B, D.B. Smith, E. H. Baker, S. M. Brecher and K. Gupta. 2012. Has the Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Increased Trimethoprim-Sulfamethoxazole Use and Resistance? A 10-Year Time Series Analysis. Antimicrob. Agents and Chemother. 56:5655-60
  37. Helbig, S., Brecher SM, and Serrao, R. 2013. Corynebacterium striatum Cardiovascular Implantable Electronic Device Infection. Infectious Diseases in Clinical Practice. 21:401-404
  38. Waslawki, S., E.S. Lo, S.A. Ewing, V.B. Young, D.H. Arnoff, S.E. Sharp, S.M. Weekley-Novak, M. Johnson, S. M. Brecher, D.W. Newton, and S.T. Walk. 2013. Clostridium difficile Ribotype Diversity at Six Health Care Institutes in the United States. J. Clin Microbiol. 51:1938-1941
  39. Brecher SM, Novak-Weekley, SM, Nagy E. 2013. Laboratory Diagnosis of Clostridium difficile Infections: There is Light at the End of the Colon. Clinical Infectious Diseases. 57:1175-1181
Abstracts
^ back to index
  1. Brecher, S. and J. van Houte. Oral Establishment of Actinomyces viscosus in Sprague-Dawley Rats of Various Ages. J. Dent. Res. 55:177 (Special Issue B), 1976.
  2. Brecher, S. and J. van Houte. Studies of the Colonization of Actinomyces viscosus in Rats of Different Ages. J. Dent. Res. 56:34 (Special Issue B), 1977.
  3. Brecher, S. and J. van Houte. The Role of Colonization in the Virulence of Actinomyces viscosus Strains T14-Vi and T14-Av. J. Dent. Res. 57:789 (Special Issue A), 1978.
  4. Brecher, S. and J. van Houte. The Effect of Dietary Carbohydrates on the Colonization of Actinomyces viscosus in Sprague-Dawley Rats. J. Dent. Res. 59:95 (Special Issue A), 1980.
  5. Brecher, S. Extraneous Testing of Cerebrospinal Fluid for Fungi and Mycobacteria. Abstracts of the ASM Annual Meeting. U80. 1987.
  6. Manning, M., D.E. Craven, R. Facklam, K.D. Stottmeier, K. Brown, S. Brecher and W.R. McCabe. Discrepancies Between Latex Agglutination and Co-agglutination Methods for Serogrouping Group F Beta-hemolytic Streptococci. Abstracts of the ASM Annual Meeting. C92. 1987.
  7. Brecher, S.M., A. Durbin and M. Riedel. Overutilization of Stool for Culture and Parasitology on Specimens from Adult Inpatients. Abstracts of the ASM Annual Mseeting. C342. 1989.
  8. Coughlin, R., C. Fong, S. Brecher, D. Marciani, M. Pickett. Comparison of Clostridium difficile cytotoxin titer with titers of Toxin A and Toxin B by Enzyme Immunoassay (EIA). Abstracts of the ASM Annual Meeting. C99. 1991.
  9. Stahl-Bayliss, C., C. Chelle, S. Brecher, K. Jim, J. Barbato. In-vitro comparison of the bactericidal activity of 5 hand cleansers and 2 topical antiseptics. Abstracts of the ASM Annual Meeting. L20. 1991.
  10. Maslow, J.,N., S. Loring, A. Durbin, S. Brecher, and R.D. Arbeit, Klebsiella Isolates Designated as K. pneumoniae and K. oxytoca by API and Vitek Were Identified as Clonal by Pulsed Field Gel Electrophoresis (PFGE). Abstracts of ICAAC. 1522. 1991.
  11. Toneguzzo, F., K. Stottmeier and S. Brecher. Novel, Rapid Test System to Determine Mycobacterial Antibiotic Susceptibility. Abstracts of the ASM Annual Meeting. U36. 1993
  12. Jones, R.N. and the Enterococcus Study Group. Emerging Multiply Resistant Enterococci (MRE) among Clinical Isolates: Prevalence Data from 97 Medical Centers. Abstracts of ICCAC. 1052. 1993
  13. Maslow, J.N., S, Brecher, A. Durbin, J. Gunn, M. Barlow, and R.D. Arbeit. Diversity Among Strains of Methicillin-Resistant Staphylococcus aureus (MRSA) from Patients with Long-term Colonization. Abstr. 143. Abstr, Annu. Meet. Infect. Dis. Soc. Am. 1993.
  14. Boling, E., A. Durbin and S. Brecher. An Image-Processing Antimicrobial Disk Suceptibilty System. Abstracts of the ASM Annual Meeting. C342. May,1995.
  15. Brecher, S. M., E. Patalas, A. Durbin, D. Pizzuto and S. Chodosh. Gram Stains and Cultures from Sputum Collected for 24 Hours in Selected Patients with Acute Exacerbations of Chronic Bronchitis. Abstracts of the ASM Annual Meeting. C226 May,1996.
  16. Basse, L, S. M. Brecher, S. Abraham, and J. N. Maslow. Antibiotic Resistance Among Isolates of E. coli from Chimpanzees with Contact to Humans. Presented at the Infectious Disease Society Meetings (September 1996).
  17. Smole, S.C., E. Aronson, A. Durbin, S.M. Brecher, R.D. Arbeit. Sensitivity and Specificity of an Improved Rapid Latex Agglutination Test for the Identification of Methicillin-sensitive and -resistant Staphylococcus aureus. Abstracts of the ASM Annual Meeting. C-206. 1997.
  18. Argyros, F.C., S. M. Brecher, F. Rosenberg, and R.D. Arbeit. Are Salad Vegetables a Source of Nosocomial Pseudomonas aeruginosa Infection? A Molecular Analysis. Abstracts of the ASM Annual Meeting. C12. 1997
  19. Clairmont, C. et. al. Genetically modified Salmonella typhimurium VNP20009 a Novel Anti-cancer Agent: Bio-distribution, Genetic Stability, Selective Tumor Accumulation and Anti-tumor Efficacy. Gene Therapy of Cancer Annual Meeting, 1999.
  20. El-Sayed , I et al. Rapid Identification of Bacteria Causing Otitis Media Using Steady State Fournier Transform Infrared Spectroscopy. Presented at the Annual Meeting of the American Society of Pediatric Otolaryngnologists. 2000.
  21. Brecher, S. M., A. Durbin and D. Soja. A Ten Year Gram-Negative ICU Surveillance Study to Monitor Prevalence, Emergence of Antimicrobial Resistance and Cross-Resistance. Abstracts of the ASM Annual Meeting. A-75. 2001
  22. Oliveira, K., S M. Brecher, et al. Direct Identification of Staphylococcus aureus from Positive Blood Cultures. Abstracts of the ASM Annual Meeting. C-236. 2002
  23. Brecher, S.M. and D. Soja. Analysis of the MIC Distribution of E. coli and Klebsiella spp. From Intensive Care Units: Percent Susceptible at Discrete MIC Values. Abstracts of the ASM Annual Meeting, A-147. 2004
  24. Gavin, P.J. et al. Assessment of the NCCLS Susceptibility Breakpoints for Piperacillin/Tazobactam in Infections Caused by ESBL-Producing Escherichia coli and Klebsiella species Based on Therapy Outcome. Presented at the Infectious Disease Society of America Annual Meeting. Abstract 440. 2004
  25. Oliveira, K., S. M. Brecher, et al. Rapid Identification of S. aureus and differentiation between MRSA and MSSA from Blood Culture Bottles using PNA FISH and MRSA Evigene. Presented at the Infectious Disease Society of America meeting, 2005 Abstract 424
  26. Hasse, G. et al. Evaluation of Dual Color S. aureus/CNS PNA FISH for Simultaneous Identification of Staphylococcus aureus and Coagulase-negative Staphylococci Directly from Positive Blood Culture Bottles. American Society for Microbiology Annual Meeting. May, 2006. Orlando, FL Abstract C-059
  27. Oliveira, K, S. M. Brecher et al. Rapid Identification of S. aureus and Differentiation between MRSA and MSSA Directly from Positive Blood Culture Bottles using S. aureus EVIGENE and MRSA EVIGENE. American Society for Microbiology Annual Meeting. May, 2006. Orlando, FL Abstract C-115
  28. Tilahun, Y., S.M. Brecher et al. Rapid Identification of Vancomycin-Resistant Enterococci Directly from Positive Blood Culture Bottles using VR EVIGENE. American Society for Microbiology. May, 2007. Abstract C-032 Toronto
  29. Baker, S., S. Brecher et al. MRSA Nasal and Extra-Nasal Colonization on Admission to an Acute care VA Hospital. SHEA Abstract 225. San Diego, CA 2009
  30. Brecher, S. M. et al. 2009. Clostridium difficile EIA and PCR Testing of EIA High Positive, Low Positive and High Negative Stool Samples. ICAAC Abstract D-1422 , San Francisco September, 2009
  31. Tenover, FC et al. Comparison of Nasal and Blood Culture Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA) from Patients in US Hospitals. ICAAC Abstract C2-1482. Boston September, 2010.
  32. Strymish, J., S. Brecher, et al.. Multiple Interventions are Necessary to Decrease C. difficile Infections. SHEA Abstract 188. Dallas, TX. April, 2011
  33. Caffrey, A. R., K. LaPlante and S. M. Brecher. Time from Specimen Collection to Culture and Susceptibility Report Completion for Staphylococcus aureus: An Opportunity for Healthcare Quality Improvement. IDSA Abstract 1006. Boston. October, 2011
  34. Linsenmyer, K et al. Fosfomycin Resistance is associated with receipt of Incorrect Empiric Therapy for Multidrug Resistant Uropathogens. IDSA Week Abstract 1591. 2013
  35. Mudie, K. and S. M. Brecher. Can MALDI-TOF Replace Gram Stains When Working Up Colonies on Agar Plates? Submitted to ASM Annual Meeting. 2014
Invited Lectures (2000-2014)
^ back to index
  • South Central Association for Clinical Microbiology. Presented the Annual Mickey King Lecture on Antibiotic Resistance. Louisville, KY. April, 2000
  • Maine Academy of Family Physicians, 8th Annual Family Practice Update. “The Prudent Use of Antibiotics”. Sebasco Harbor, Maine. May, 2000.
  • NE Regional Fall Joint Conference ( MLT, MT, CLMA). Role of the Clinical Microbiology Laboratory in Infection Control. October, 2000.
  • Southern California American Society for Microbiology. Invited Keynote Speaker/Foundation Lecture on Antibiotic Resistance. November, 2000.
  • American Society for Microbiology. Invited Workshop Convener and Speaker. Bacterial Resistance: Mechanisms, Detection, Pharmacology, and Molecular Epidemiology. Orlando (May, 2001) and Chicago (December, 2001).
  • American Society for Microbiology Annual Meeting. Convener and Speaker: Examining Resistance in Streptococcus pneumoniae : Perspectives. Orlando, May, 2001.
  • Northeast Association for Microbiology and Infectious Disease. Cases Studies. Andover, MA June, 2001
  • Massachusetts Department of Public Health, Alliance for the Prudent use of Antibiotics and Others. Organizing Committee Member and Speaker at a symposium “Antibiotics: Yesterday, Today and Tomorrow. My talk was: The History of Antibiotics: How Miracle Drugs Created Miracle Bugs. October, 2001.
  • Commonwealth Journal. University of Massachusetts Public Radio. “The Microbes Fight Back”. Radio Interview. January, 2002.
  • 24th Annual Infectious Disease and Antibiotic Therapy Conference. The Bacterial Revolution – The Bugs Fight Back. Orlando, FL. July, 2002
  • American Society for Microbiology. Invited Workshop Convener and Speaker. Bacterial Resistance: Mechanisms, Detection, Pharmacology, and Molecular Epidemiology. Salt Lake City, 2002
  • American Society for Microbiology (ICCAC). Invited Workshop Convener and Speaker. Bacterial Resistance: Mechanisms, Detection, Pharmacology, and Molecular Epidemiology. San Diego, 2002
  • Massachusetts State CDC Active Surveillance Workshop. NCCLS Standards for Antimicrobial Susceptibility Data (M39 Guidelines). October, 2002
  • Boston Medical Center, Surgical Service Rounds. Update on Nosocomial Antibiotic Resistance. February, 2003
  • Medicine for Today, Cardondale Memorial Hospital. Antibiotic Resistance Bacterial Pathogens in the Respiratory Tract. Carbondale, Illinois. February, 2003
  • Third Annual North American Woman’s Health Forum. The Impact of Antimicrobial Resistance on Community Acquired Respiratory Tract Infections in Primary Care Today. Anaheim. March, 2003
  • Rhode Island Hospital and Brown Medical School. Allergy and Immunology Grand Rounds. Antibiotic Resistance in Respiratory Pathogens. Providence. March, 2003
  • Quad County Medical Society Annual Internal Medicine Symposium. An Overview of Antibiotic Resistance. Poplar Bluff, Missouri. March, 2003
  • Investigator’s Meeting. Cubist Pharmaceuticals. Update on Resistance in Gram Positive Bacteria. Lexington, MA April, 2003
  • New England Directors of Microbiology. Invasive Candidiasis. Sturbridge, MA May, 2003
  • American Society for Microbiology (Invited Workshop Convener and Speaker). Bacterial Resistance: Mechanisms, Detection, Pharmacology, and Molecular Epidemiology. Washington, DC, May, 2003
  • American Society for Microbiology (ICCAC). Invited Workshop Convener and Speaker. Bacterial Resistance: Mechanisms, Detection, Pharmacology, and Molecular Epidemiology. Chicago, 2003
  • American College of Chest Physicians. Controversies in Resistance Patterns in CAP and AECB: PROTEKT US Invited speaker. Orlando. October, 2003
  • Massachusetts Thoracic Society, Infectious Disease Update. Lahey Clinic. October, 2003
  • Comcast Television Interview on Bacterial Resistance to Antibiotics with Barry Nolan, December, 2003
  • Danbury Hospital, Medical Grand Rounds Update on Antibiotic Resistance, March, 2004
  • ASM National Teleconference, How Miracle Drugs Created Miracle Bugs, May, 2004
  • Missouri Association of Health Plan Providers. Antibiotic Resistance in Respiratory Tract Infections. Ozark Lakes, MIssouri. October, 2004.
  • American Society for Microbiology (ICCAC). Invited Workshop Speaker. Resistance Issues in SDtaphylococci and Enterococci. Washington, DC October, 2004
  • Spinal Chord Injury Medicine, 13th Educational Symposium. An Overview of Antibiotic Resistance. Dedham, MA November, 2004
  • Pri-Med Atlantic. Invited Symposium. Petri vs People: You be the Judge. Washington, DC November, 2004
  • American Association of Periodontologists. Antibiotic Resistance. Orlando, FL November, 2004
  • Pri-Med Update. Acute Bacterial Exacerbations of Chronic Bronchitis. Cincinnati, OH April, 2005
  • New England Directors of Microbiology. Update on Increased Virulence in Clostridium difficile. Sturbridge, MA April, 2005
  • Infectious Diseases Pharmacotherapy. 8th Annual Conference. Antibiotic Resistance in the Community. Carefree, AZ May, 2005.
  • Infectious Diseases Pharmacotherapy. 8th Annual Conference. Antibiotic Resistance in Nosocomial Pathogens. Carefree, AZ May, 2005
  • Annual Meeting. Update on Woman’s Health (NPACE). An Overview of Antibiotic Resistance. Phoenix, AZ May, 2005
  • American Society for Microbiology Annual Meeting. Convener and presenter. The Changing Faces of the Pneumococcus. Atlanta, GA June, 2005
  • Clinical Medicine Update. Live TV and Webcast. “Antimicrobial Resistance: An Evolving Challenge in the Treatment of Respiratory Tract Infections”. Waukesha, WI. June, 2005
  • New England Regional Women’s Health and Older Adult Conference. Key note lecture on Antibiotic Resistance and session lecture on “Improving Outcomes in Outpatient Respiratory Tract Infections.” Falmouth, MA June, 2005
  • Pharm-Med (Primed). “Update on Antibiotic Resistance”. Detroit, MI and Boston, MA September and October, 2005
  • Yale Medical School. Pathology Grand Rounds. “An Overview of Antibiotic Resistance”. October, 2005
  • NPACE Women’s Health Conference. “Community Acquired Pneumonia”. Boston, MA November, 2005
  • Northeast Branch, American Society for Microbiology Regional Meeting. “The New Chief of Staph and Others that Want to Be”. Dedham, MA December, 2005
  • ICAAC Workshop on Antibiotic Resistance. Lectured on Antibiotic Resistance and Detection in S. aureus and Enterococci. Washington, DC. December, 2005
  • 34th Annual Joint Conference New Jersey Thoracic Society, American Thoracic Society, NJ Chapter, American College of Chest Physicians and the American Lung Association of NJ. “Pneumonia: Treatment Guidelines and Antibiotic Resistance” New Brunswick, NJ March, 2006
  • Infectious Diseases for Practicing Clinicians 2006, Lahey Clinic Medical Center, Department of Pharmacy. “Understanding Antibiotic Susceptibility Testing and the New Big Bad Bugs that are Making This Difficult”. Burlington, MA March, 2006
  • The Rhode Island Society of Health-System Pharmacists. Reexamining Treatment Practices for Complicated Clostridium difficile-Associated Disease. Warwick, RI March 2006
  • Pri-Med Updates: Numerous Locations. Updates on Antibiotic Resistance (Los Angeles, Toledo, Atlanta, Houston, Westchester, Omaha, Providence, Miami, East Rutherford, St Paul). 2006-2007
  • The Franklin Koontz Memorial Lecture. Pathology Grand Rounds. "The New 'Chief of Staph', the 'difficile' Bacillus, and Other Pending Disasters". Univ of Iowa Medical School. September, 2006
  • ICAAC Workshop on Antibiotic Resistance. Lectured on Antibiotic Resistance and Detection in S. aureus and Enterococci. San Francisco, CA. September, 2006
  • Georgia Academy of Family Physicians. "The New 'Chief of Staph', the 'difficile' Bacillus, and Other Pending Disasters". Atlanta, GA. November, 2006
  • The Infection Connection, Merit Healthcare. "The New 'Chief of Staph', the 'difficile' Bacillus, and Other Pending Disasters". Fargo, ND. February, 2007
  • Robert Michael Education Foundation Lecture Series. "Optimizing Outcomes in Severe Clostridium difficile Associated Disease". (Florida, Alabama, Georgia, Virginia). 2007.
  • Optimizing Outcomes in Severe Clostridium difficile Associated Disease: A Closer Look at Infection Control and Therapeutic Strategies 2007 Numerous Locations
  • Pri-Med Updates. What you Always Wanted to Know About the New “Chief of Staph”, the “difficile” Bacillus, and Other Pending Disasters 2007 Numerous Locations
  • Wayne State School of Pharmacy Symposium. Wayne State Medical School. “The ABC’s of Resistance”. Detroit, MI September, 2007
  • ICAAC Workshop on Antibiotic Resistance. Lectured on Antibiotic Resistance and Detection in S. aureus and Enterococci. Chicago, IL. September, 2007
  • Medical Grand Rounds, Brigham and Women’s Hospital. Antibiotic Resistance. September, 2007, Boston, MA
  • Alliance for the Prudent Use of Antibiotics World Conference on Infectious Disease. Addressing the Challenge of C. difficile. October, 2007
  • New England Spinal Cord Annual Symposium. Antibiotic Resistance. Dedham, MA November, 2007
  • NE ASM 42nd Annual Meeting. Convener and speaker. The Bacterial Supremacy: Sources, Theories and Realities of Antibiotic Resistant Bacteria. Susceptibility Testing: No Size Fits All and Presented Case Studies. The Conference Center at Harvard Medical School. Boston, MA November, 2007
  • Pri-Med Updates. What you Always Wanted to Know About the New “Chief of Staph” (CA-MRSA), the “difficile” Bacillus, and Other Pending Disasters 2008 (Nashville, Dallas, Princeton, Long Beach, Cincinnati, and Houston)
  • Optimizing Outcomes in Severe Clostridium difficile Associated Disease: A Closer Look at Infection Control and Therapeutic Strategies 2008 (Kentucky, Ohio, Chicago, Boston, Indianapolis, Maryland, New Hampshire, etc.)
  • Update on Staphylococcal Infections. Henry Ford Hospital. September, 2008
  • American Society for Microbiology Annual Meeting. Antibiotic Resistance Workshop Convener . The Bacterial Supremacy. I covered Staphylococci and Enterococci. June, 2008
  • Taller Latinoamericano de Resistencia Antimicrobia. European Society of Clinical Microbiology and Infectious Disease, American Society for Microbiology and y la Association Mexicana de Infectologia y Microbiologia Clinica. Detection of Resistance in Staphylococcus aureus. Detection of resistance in Enterococci. Mexico City, 2008
  • American Society for Microbiology Annual Meeting. Antibiotic Resistance Workshop Convener and Speaker. The Bacterial Supremacy. I covered Staphylococci and Enterococci. May, 2009
  • Pri-Med Updates. What you Always Wanted to Know About the New “Chief of Staph” (CA-MRSA), the “difficile” Bacillus, and Other Pending Disasters . Florida. June, 2009
  • Clostridium difficile Infection: Strategic Approaches for Better Outcomes. Virginia and South Carolina. June and July 2009
  • ICAAC ASM Annual Meeting. Workshop Speaker on Staphylococci and Enterococci. San Francisco, September, 2009
  • SPICEGYPT, ESCMID and ASM Workshop on Antimicrobial Resistance and Bacterial Pathogens. Invited Speaker. Cairo, Egypt. October, 2009
  • Massachusetts College of Pharmacy Educational Update. Invited Speaker on Emerging Antibiotic resistance Danvers, MA. October, 2009.
  • NYC ASM. Invited Speaker. “Is it “Difficile”? Not for the Chief of “Staph”. New York City. October, 2009.
  • Northeast Branch, ASM Fall Meeting. “Are these difficile cases? Not for the Chief of Staph. Dartmouth, MA November, 2009.
  • Indiana State Department of Health: Healthcare Associated Infection Initiative. Invited Speaker on Clostridium difficile Infections. Indianapolis, IN March 2010
  • Lahey Clinic CE Symposium Infectious Diseases: Invited speaker. “Interpretation of Confusing Laboratory Results Recently Made Even More Confusing: An Attempt to De-Confuse.” Burlington, MA March 2010
  • Boston University School of Medicine, Boston Medical Center: Pathology Grand Rounds. Update on Staphylococcal, C. difficile and Multi-Drug Resistant Gram Negative Infections. Boston, MA March, 2010
  • ACLS-CNE Annual Meeting. Update on C. difficile. Providence, RI May 2010
  • American Society for Microbiology Annual Meeting. Convener and Speaker. Antibiotic Resistance Workshop San Diego, CA May, 2010
  • American Society for Microbiology Annual Meeting. Symposium on C. difficile. Convener and speaker. Overview of C. difficile Infections (CDI). San Diego, CA May, 2010
  • American Society for Microbiology. ICAAC. Speaker at Workshop: Antibiotic Resistance Among Bacterial Pathogens: Mechanisms, Detection and Molecular Epidemiology. Boston, MA September, 2010
  • New England Directors of Microbiology. PCR: Is the Juice Worth the Squeeze? Sturbridge, MA October, 2
  • Eastern Pennsylvania Branch, ASM. Speaker. The New Wave of C. difficile-Associated Infections and Testing Options. Philadelphia, PA November 2010
  • American Society for Microbiology Annual Meeting: Invited Speaker: Diagnosis and Epidemiology of Clostridium difficile Infections. Assessment of C. difficile Diagnostics in the Setting of Recent Guidelines: Becoming Less Difficile. ASM Annual Meeting. New Orleans 2011
  • American Society for Microbiology Annual Meeting. Convener and Speaker. Resistant Bugs, Diagnostic Dilemmas, and Molecular Problem Solving (all day workshop) New Orleans, LA May, 2011
  • NACMID Annual Meeting. Diagnosing CDI is Becoming Less difficile. Springfield, MA June, 2011
  • Lahey Clinic CE Symposium: Infectious Diseases 2011. Clostridium difficile: Risk Factors, Detection and Treatment Options. Is There Light at the end of the Colon?. September, 2011
  • Satellite Symposia at ICAAC and IDSA. Clostridium difficile Infection. Clinical Update: Emerging Therapies and Recurrence Prevention, C. difficile Diagnostic Testing: What’s New? Chicago and Boston. September and October 2011
  • Northeast Association for Microbiology Regional Meeting. Speaker/Panel Member. Update on C. difficile Randolph, MA October, 2011
  • Massachusetts State Laboratory Institute. Invited speaker. It Ain’t That Difficile Anymore. November, 2011
  • Grand Rounds on C. difficile. Roger Williams Hospital/Providence , RI January 2012
  • First Coast Infectious Disease and Clinical Microbiology. “Initial” Reasons to Retire: CLSI, FDA, ESBL, ampC, KPC, VISA, CDI, EIA, PCR and ME. St. Augustine, Florida. January, 2012
  • Illinois Society for Microbiology. 2012 Spring Meeting. C. difficile Progress Report: It is getting Less Difficile. April 2012.
  • Mercy Hospital. Portland, Maine. Medical Grand Rounds on C. difficile. April, 2012
  • Eastern Maine Medical Center. Bangor, Maine. Adult and Pediatric Grand Rounds on C. difficile. May, 2012
  • American Society for Microbiology Annual Meeting. Convener and Speaker : Workshop on Resistant Bugs and Other Problems. ASM Annual Meeting. San Francisco, June 2012
  • Veterans Health Administration Employee Education System. Multi-Drug-Resistant Organisms: Antibiotic Stewardship. Invited Speaker. Atlanta (July); San Antonio (August). 2012
  • ASM ICAAC. Workshop Convener and Speaker. C. difficile Infections and S. aureus antibiotic resistance issues. San Francisco, September, 2012
  • New York City ASM. Invited Speaker. Initial Reasons to Retire. Overview of Antibiotic Resistance and C. difficile. NY City, November, 2012
  • Louisville Dental Education Symposium. . From Tragedy to Triumph to Trepidation: Antibiotics at Age 70. 3 hour lecture to 450-500 Dental professionals. Louisville, January, 2013
  • VA Boston Healthcare System. Medical Grand Rounds. Antibiotics at Age 70. January, 2013
  • First Coast Infectious Disease and Clinical Microbiology Symposium. Invited Speaker. From Tragedy to Triumph to Trepidation. Antibiotics at Age 70, St. Augustine, FL February, 2013
  • APIC 2013 Clostridium difficile Educational and Consensus Conference. Invited Speaker and Panelist. Baltimore March, 2013
  • Association of Clinical Scientists Annual Meeting. Invited Speaker. From Tragedy to Triumph to Trepidation; Antibiotics at Age 70. Boston, MA. May, 2013
  • Tri-Mark Infectious Disease Conference. From Tragedy to Triumph to Trepidation: Antibiotics at Age 70. Randolph, MA May, 2013
  • ASM Annual Meeting. Antibiotic Resistance. Invited speaker and panelist. Denver, CO. May, 2013
  • New England Baptist Hospital. Medical Grand Rounds. From Tragedy to Triumph to Trepidation: Antibiotics at Age 70. July, 2013
  • ASM ICAAC. Workshop Convener and Speaker. S. aureus antibiotic resistance issues. San Francisco, Denver, September, 2013
  • Association for the Healthcare Environment, Annual Meeting, Invited Speaker. From Tragedy to Triumph to Trepidation; Antibiotics at Age 70. Indianapolis. September, 2013
  • Boston Area Anti-Infective Resistance Network. Rapid Bacterial Diagnostics: Are We There Yet? Waltham, MA November, 2013
  • APIC National Teleconference; Invited Speaker. From Tragedy to Triumph to Trepidation; Antibiotics at Age 70. Boston, MA November, 2013
  • VA National Infectious Disease Conference on Multi-Drug Resistant Organisms/Carbapenemase-Resistant Enterobacteriaceae. Invited speaker: Laboratory Identification of CRE’s, ESBLs, and ampCs. San Antonio, TX January 2014